tm logo
Trademark Search
FROM NEUTRON TO PATIENT

View On IC.GC.CA

FROM NEUTRON TO PATIENT
SEARCHED

on 18 Aug 2023

Last Applicant/ Owned by

POINT BIOPHARMA USA INC.

4850 West 78th St.Indianapolis IN 46268

US

Serial Number

2183842 filed on 31st Mar 2022

Correspondent Address

365, rue Abraham-Martinbureau 600Québec

QUEBEC

CA

G1K8N2

FROM NEUTRON TO PATIENT

Trademark usage description

pharmaceutical preparations for the diagnosis and treatment of cancer and tumors; pharmaceutical preparations for the diagnosis and treatment of oncol Read More

Classification Information

Class [005]
Pharmaceutical preparations for the diagnosis and treatment of cancer and tumors; pharmaceutical preparations for the diagnosis and treatment of oncological diseases; radioactive pharmaceutical substances for use in nuclear medicine, intended for medical treatments and imaging; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals.

Classification kind code

11

Class [042]
Pharmaceutical research and development services; providing medical research information in the fields of pharmaceuticals, oncology and nuclear medicine.

Classification kind code

11

Mark Details

Serial Number

2183842

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 30th Jan 2024		Agent Changed
Submitted for opposition 22
on 18th Aug 2023		Search Recorded
Submitted for opposition 20
on 18th Aug 2023		Examiner's First Report
Submitted for opposition 223
on 18th Aug 2023		Total Provisional Refusal
Submitted for opposition 256
on 06th Mar 2023		Notification of Possible Opposition Sent
Submitted for opposition 257
on 05th May 2022		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 05th May 2022		Formalized
Submitted for opposition 1
on 05th May 2022		Created
Submitted for opposition 228
on 31st Mar 2022		International Registration
Submitted for opposition 30
on 31st Mar 2022		Filed